Russia-Cuba: a New Round of Cooperation
Pharmaceutical company R-PHARM, research center “ChemRar”, First Oncology Scientific-Consultation Center (FOSCC) and Institute of Human Stem Cells have signed agreements on strategic cooperation in the field of innovations and biotechnologies with the Cuba Center of Genetic Engineering and Biotechnologies.
The documents reflect mutual understanding of the Cuban and Russian parties in the field of pharmaceutics, bioinformatics, exchange of genetic information and establishment of business start-ups at Skolkovo. Ultimately it refers to mutual intensive cooperation of scientists from the two countries, specialist exchange, development of new pharmaceutical products and mutual help in global distribution. The ceremony of signing documents by Victor Vexelberg, President of Skolkovo, reported the importance of the event. He stressed, that achievements of Cuban medicine assure the success of cooperation.